July 29 (Reuters) – Glenmark Pharmaceuticals Ltd: * GLENMARK PHARMACEUTICALS INC., USA LAUNCHES SUGAMMADEX INJECTION, 200 MG/2 ML (100 MG/ML) AND 500 MG/5 ML (100 MG/ML) SINGLE-DOSE VIALS Source text:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)